The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re 2020 Annual Report

4 Jan 2021 07:00

RNS Number : 3954K
Alpha Growth PLC
04 January 2021
 

Alpha Growth plc

("Alpha", or the "Company")

 

 Correction to the 2020 Annual Report

 

Further to the Company's RNS of 31 December 2020, Alpha Growth Plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class apologises for a drafting error in regard to a statement contained in its Annual Report for the year ended 31 August 2020 (the '2020 Annual Report').

 

The 2020 Annual Report which was published on 31 December 2020, under subsequent events since end of year in the Strategic Report section, a statement was made in relation to an equity placing that was offered to and briefly being considered by the Company at the time of the drafting of the 2020 Annual Report.

 

Regrettably, and the Directors apologise for the oversight, the statement was not removed from the final draft 2020 Annual Report after the Company elected not to proceed with the placing. Please be assured that the Company will make announcements when material events are to occur.

 

The above correction does not affect the references in the same section of the 2020 Annual Report to the placing which the Company completed in September 2020 to raise £454,000.

 

The Company will be providing a planned trading update in January and continues to execute on its BlackOak fund and other strategies with the resources on hand.

 

In compliance with Listing Rule 14.3.6 of the UK Financial Conduct Authority ('FCA'), the corrected 2020 Annual Report will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The corrected 2020 Annual Report is available at www.algwplc.com .

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth Plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com

 

 

Pello Capital Limited

+44 (0) 20 7710 9610

Mark Treharne

mt@pellocapital.com

 

 

About Alpha Growth Plc

Specialist in Longevity Assets

Alpha Growth Plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

SLS Assets and Non-correlation

A SLS refers to the sale of an existing life insurance policy to a third party for a cash payment. Such a payment will be in excess of the policy's surrender value, but less than its face value. After the sale, the purchaser becomes the policy's beneficiary and assumes payment of its premiums. There are many reasons why policy holders may choose to sell their life insurance policies and sales are usually only undertaken when the insured person doesn't have a known life-threatening illness. The SLS provides individuals with policies the option to realise value from an asset under a regulated transaction. As a longevity asset, the SLS is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages SLS Assets that originate in the USA where the SLS market is highly regulated.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSGBGDBXXGDGBS
Date   Source Headline
9th Mar 202011:00 amRNSPrice Monitoring Extension
26th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20208:00 amRNSResult of AGM
31st Dec 20197:00 amRNSPublication of the 2019 Annual Report
17th Dec 20197:00 amRNSTrack Record Review, Placing & Total Voting Rights
2nd Dec 20197:00 amRNSAdvancement of Warehousing SPV and Subscription
11th Nov 20197:00 amRNSAppointments and Board changes
20th Sep 201911:46 amRNSSecond Price Monitoring Extn
20th Sep 201911:45 amRNSPrice Monitoring Extension
18th Sep 20193:31 pmRNSAlpha Growth - Holding(s) in Company
12th Aug 20197:00 amRNSHolding(s) in Company
15th Jul 20197:00 amRNSCorporate Update
2nd Jul 20199:14 amRNSHolding(s) in Company
5th Jun 20197:00 amRNSIssue of Equity & TVR
16th May 201912:00 pmRNSHolding(s) in Company
10th May 20192:16 pmRNSPublication of Prospectus
3rd May 201911:05 amRNSSecond Price Monitoring Extn
3rd May 201911:00 amRNSPrice Monitoring Extension
30th Apr 20197:20 amRNSProposed Placing
30th Apr 20197:00 amRNSBlackOak Alpha Growth Fund Launch
29th Apr 20194:00 pmRNSInterim Results
18th Apr 20192:00 pmRNSPrice Monitoring Extension
29th Mar 20192:28 pmRNSHolding(s) in Company
6th Mar 20197:00 amRNSBoard Changes
4th Mar 201910:10 amRNSResult of AGM
4th Mar 20197:00 amRNSCorporate Update
1st Mar 20197:00 amRNSAcquisition of Colva
20th Feb 201910:28 amRNSIssue of Equity
13th Feb 20197:00 amRNSAlpha Growth Investor Meeting
7th Feb 20197:00 amRNSAlpha Growth - Notice of Annual General Meeting
30th Jan 20197:00 amRNSAcquisition: Completion of ALM Acquisition
24th Dec 201810:52 amRNSFinal Results
21st Nov 20187:00 amRNSSL Investment Management Joint Venture
15th Nov 201811:36 amRNSHolding(s) in Company
24th Sep 20181:59 pmRNSHolding(s) in Company
17th Sep 20184:40 pmRNSSecond Price Monitoring Extn
17th Sep 20184:35 pmRNSPrice Monitoring Extension
17th Sep 20182:05 pmRNSSecond Price Monitoring Extn
17th Sep 20182:00 pmRNSPrice Monitoring Extension
17th Sep 201812:18 pmRNSHolding(s) in Company
17th Sep 20187:00 amRNSIssue of Equity and Director/PDMR Dealing
4th Sep 20185:14 pmRNSHolding(s) in Company
30th Aug 201812:16 pmRNSHolding(s) in Company
24th Aug 201812:59 pmRNSNotification of Major Holdings
18th Jul 20187:00 amRNSAcquisition of ALM
13th Jun 20187:00 amRNSHolding(s) in Company
8th Jun 20187:00 amRNSEngagement of Devonshire Warwick, Investor Event
1st Jun 20187:00 amRNSAppointment of Chief Operating Officer
11th May 20184:03 pmRNSHolding(s) in Company
30th Apr 20181:00 pmRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.